These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23537934)

  • 21. Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease.
    Frank T; Klinker F; Falkenburger BH; Laage R; Lühder F; Göricke B; Schneider A; Neurath H; Desel H; Liebetanz D; Bähr M; Weishaupt JH
    Brain; 2012 Jun; 135(Pt 6):1914-25. PubMed ID: 22427327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetrahydrobiopterin shows chaperone activity for tyrosine hydroxylase.
    Thöny B; Calvo AC; Scherer T; Svebak RM; Haavik J; Blau N; Martinez A
    J Neurochem; 2008 Jul; 106(2):672-81. PubMed ID: 18419768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
    J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
    Febbraro F; Andersen KJ; Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
    Exp Neurol; 2013 Sep; 247():45-58. PubMed ID: 23531432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of tyrosine hydroxylase and BDNF in a low-dose rotenone model of Parkinson's disease.
    Johnson ME; Lim Y; Senthilkumaran M; Zhou XF; Bobrovskaya L
    J Chem Neuroanat; 2015 Dec; 70():33-41. PubMed ID: 26562783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of tetrahydrobiopterin and catecholamines in the developmental regulation of tyrosine hydroxylase level in the brain.
    Homma D; Katoh S; Tokuoka H; Ichinose H
    J Neurochem; 2013 Jul; 126(1):70-81. PubMed ID: 23647001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
    Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.
    Liu CQ; Chen Z; Liu FX; Hu DN; Luo JH
    Neuropharmacology; 2007 Dec; 53(7):832-41. PubMed ID: 17919665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of tyrosine hydroxylase in management of Parkinson's disease.
    Feve AP
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):450-5. PubMed ID: 22583428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The changes of striatal dopamine levels in the brain in rat models for Parkinson's disease after gene therapy].
    Tong H; Zhang J; Xu Q
    Zhonghua Yi Xue Za Zhi; 1996 Jul; 76(7):490-2. PubMed ID: 9275495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of tyrosine hydroxylase in lymphocytes and effect of endogenous catecholamines on lymphocyte function.
    Qiu YH; Peng YP; Jiang JM; Wang JJ
    Neuroimmunomodulation; 2004; 11(2):75-83. PubMed ID: 14758053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of electroacupuncture scalp point-through-point therapy on the expression of tyrosine hydroxylase and dopamine transporter mRNAs in substantia nigra of Parkinson's disease model rats].
    Wang S; Qi XJ; Han D
    Zhongguo Zhen Jiu; 2009 May; 29(5):391-4. PubMed ID: 19489498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyrosine hydroxylase is expressed during early heart development and is required for cardiac chamber formation.
    López-Sánchez C; Bártulos O; Martínez-Campos E; Gañán C; Valenciano AI; García-Martínez V; De Pablo F; Hernández-Sánchez C
    Cardiovasc Res; 2010 Oct; 88(1):111-20. PubMed ID: 20525643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
    Sajadi A; Bauer M; Thöny B; Aebischer P
    J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies.
    Riederer P; Rausch WD; Birkmayer W; Jellinger K; Seemann D
    J Neural Transm Suppl; 1978; (14):121-31. PubMed ID: 39974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival and migration of transplanted neural stem cell-derived dopamine cells in the brain of parkinsonian rat.
    Ahn TB; Kim JM; Kwon KM; Lee SH; Jeon BS
    Int J Neurosci; 2004 May; 114(5):575-85. PubMed ID: 15204064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
    Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
    Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.